Diabetes Care, Vol 20, Issue 4 479-483, Copyright © 1997 by American Diabetes Association

ARTICLES

Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises

GE Umpierrez, WS Clark and MT Steen
Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.

OBJECTIVE: Many newly diagnosed obese African-American patients with history of severe hyperglycemia or diabetic ketoacidosis (DKA) are able to discontinue pharmacological treatment with continued good metabolic control. However, many of these individuals relapse into hyperglycemia within 1 year. In such patients, we compared the effect of low-dose sulfonylurea and dietary therapy in the prevention of recurrence of hyperglycemia. RESEARCH DESIGN AND METHODS: We conducted an intention-to-treat study in 35 obese newly diagnosed diabetic patients (17 with DKA and 18 with severe hyperglycemia). After discontinuation of insulin, seven of 17 patients with DKA and seven of 18 patients with hyperglycemia were managed with diet and glyburide (1.25-2.5 mg/day), whereas other patients were followed with diet alone. In all patients, pancreatic insulin reserve was documented 1 day after resolution of hyperglycemic crises and within 1 week of discontinuation of insulin. Recurrence of hyperglycemia was defined as fasting blood glucose > 7.8 mmol/l (140 mg/dl) or random blood glucose > 10 mmol/l (180 mg/dl) on two or more consecutive determinations, or HbA1c > 7.5%. RESULTS: Both treatment groups were comparable in age, sex, duration of diabetes, months of insulin therapy, BMI, glucose, and HbA1c. At presentation, the acute C-peptide response to glucagon in obese DKA patients was lower than in patients with hyperglycemia (P < 0.01), but responses were comparable after discontinuation of insulin. Sulfonylurea treatment significantly reduced recurrence of hyperglycemia in both obese DKA and obese hyperglycemic patients (P = 0.03). With a median follow-up of 16 months, hyperglycemia recurred in six of 10 DKA patients and in five of 11 hyperglycemia patients treated with diet alone, compared with one of seven DKA and one of seven hyperglycemia patients treated with glyburide. Readmission with metabolic decompensation occurred in four patients treated with diet but in none of the patients treated with diet and glyburide. CONCLUSIONS: Low-dose sulfonylurea therapy prevents recurrence of hyperglycemia in newly diagnosed obese African-American patients with a history of hyperglycemic crises.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. E. Kitabchi, G. E. Umpierrez, J. N. Fisher, M. B. Murphy, and F. B. Stentz Thirty Years of Personal Experience in Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1541 - 1552. [Abstract] [Full Text] [PDF]

				G. E. Umpierrez Ketosis-Prone Type 2 Diabetes: Time to revise the classification of diabetes Diabetes Care, December 1, 2006; 29(12): 2755 - 2757. [Full Text] [PDF]

				G. E. Umpierrez, D. Smiley, and A. E. Kitabchi Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med, March 7, 2006; 144(5): 350 - 357. [Abstract] [Full Text] [PDF]

				P. Narendran, E. Estella, and S. Fourlanos Immunology of type 1 diabetes QJM, August 1, 2005; 98(8): 547 - 556. [Full Text] [PDF]

				N. Rasouli and S. C. Elbein Improved Glycemic Control in Subjects with Atypical Diabetes Results from Restored Insulin Secretion, But Not Improved Insulin Sensitivity J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6331 - 6335. [Abstract] [Full Text] [PDF]

				K. Wheeler, R. Crawford, D. McAdams, S. Benel, V. G. Dunbar, J. M. Caudle, C. George, I. El-Kebbi, D. L. Gallina, D. C. Ziemer, et al. Inpatient to Outpatient Transfer of Care in Urban Patients With Diabetes: Patterns and Determinants of Immediate Postdischarge Follow-up Arch Intern Med, February 23, 2004; 164(4): 447 - 453. [Abstract] [Full Text] [PDF]

				A. Piñero-Piloña, P. Litonjua, L. Aviles-Santa, and P. Raskin Idiopathic Type 1 Diabetes in Dallas, Texas: A 5-year experience Diabetes Care, June 1, 2001; 24(6): 1014 - 1018. [Abstract] [Full Text]